Safety and Pharmacokinetics of Abacavir (1592U89) following Oral Administration of Escalating Single Doses in Human Immunodeficiency Virus Type 1-Infected Adults

Abacavir (1592U89) is a nucleoside analog reverse transcriptase inhibitor that has been demonstrated to have selective activity against human immunodeficiency virus (HIV) in vitro and favorable safety profiles in mice and monkeys. A phase I study was conducted to evaluate the safety and pharmacokine...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Kumar, Princy N., Sweet, Donna E., McDowell, James A., Symonds, William, Lou, Yu, Hetherington, Seth, LaFon, Stephen
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 1999
Teme:
Pharmacology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC89167/
https://ncbi.nlm.nih.gov/pubmed/10049274
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items